Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Clinical trial NCT00353288 · COMPLETED

Trial details

NCT number: NCT00353288
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Varicella Rubella Measles Mumps

Start date: 2006-03-01
Primary completion: 2006-11-01
Enrollment: 446

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.